I agree to the use of cookies and have read and understood TTP Labtech’s privacy policy.

Resources (191)

Cell-based assay screening

Santa, et al. (2017). Linking High-Throughput Screens to Identify MoAs and Novel Inhibitors of Mycobacterium tuberculosis Dihydrofolate Reductase. ACS Chem Biol. 12 (9)

Cell-based assay screening, Cell-based assays

Bassat, et al. (2017). The extracellular matrix protein agrin promotes heart regeneration in mice. Nature. 547(7662):179-184

Cell-based assays

Senese, et al. (2017). Microtubins: a novel class of small synthetic microtubule targeting drugs that inhibit cancer cell proliferation. Oncotarget. 8 (61): 104007

Cell-based assays

Lo, et al. (2017). Computational cell cycle profiling of cancer cells for prioritizing FDA-approved drugs with repurposing potential. Sci Rep. 7 (1): 11261

Cell-based assay screening

Horman, et al. (2017). Functional profiling of microtumors to identify cancer associated fibroblast-derived drug targets. Oncotarget. 8 (59) 99913

Cell-based assay screening, Cell-based assays

Tang, Y. & Cheng, L. (2017). Cocktail of chemical compounds robustly promoting cell reprogramming protects liver against acute injury. Protein Cell. 8 (4) 273-283

Cell-based assay screening, Cell-based assays

Cinkornpumin, et al. (2017). A small molecule screen to identify regulators of let-7 targets. Sci Rep. 7 (1) 15973

Cell-based assay screening, Cell-based assays

Bakke, et al. (2017). Transcription factor ZNF148 is a negative regulator of human muscle differentiation. Sci Rep. 7 (1) 8138

Cell-based assay screening, Cell-based assays

Liao, X. & Kimmel, A. (2017). A Unique High‐Throughput Assay to Identify Novel Small Molecule Inhibitors of Chemotaxis and Migration. Curr Protoc Cell Biol. 74:12.11.1-12.11.13.

Cell-based assays

Zhou, et al. (2017). An integrin antagonist (MK‐0429) decreases proteinuria and renal fibrosis in the ZSF1 rat diabetic nephropathy model. Pharmacology research & perspectives. 5 (5)

Cell-based assays

Torres-Guzmán, et al. (2017). Preclinical characterization of abemaciclib in hormone receptor positive breast cancer. Anticancer drugs. 13:15

Cell-based assays

Estridge, et al. (2017). Identification of 4-Aminopyrazolopyrimidine Metabolite That May Contribute to the Hypolipidemic Effects of LY2584702 in Long Evans Diet–Induced Obese Rats. J Pharmacol Exp Ther. 362(1):108-118

Interested? Get in touch to start the journey

Find help through our cross-domain support package

Find out where you can see our technologies in action

Get up to speed with our news